References
- Allarneh A., Saxena M., Biswas G., Raj H. G., Singh J., Srivastava. Piperine, a plant alkaloid of the piper species, enhances the bioavailability of aflatoxin B1 in rat tissues. Cancer Letters 1991; 195–199
- Atal C. K., Dubey R. K., Singh J. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. Journal of Pharmacology and Exponential Therapeutics 1985; 232: 258–262
- Bocker R. Rapid analyses of hexobarbital and its main metabolites in mice by high performance liquid chromatography. Journal of Chromatography 1982; 228: 350–354
- Greenlee W. F., Poland A. An improved assay of 7‐ethoxycouinarin‐o‐deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3‐methylcholanthrene and 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin. Journal of Pharmacology and Experimental Therapeutics 1978; 205: 596–605
- Jin H. S., Won S. M., Lee M. G., Park S. S., Gelboin H. V., Kim N. D. Phenotyping of phenytoin treated rat liver cytochrome P‐450 with monoclonal antibodies. Korean Journal of Toxicology 1991; 7: 1–12
- Kim N. D., Yoo J. K., Won S. M., Park S. S., Gelboin H. V. Phenytoin induction of P4502B in mouse: effects of hexobarbital hydroxylase activity. Xenobiotica 1993; 23: 217–225
- Kim S. C. Purification of thiazole‐ and pyrazine‐inducible microsomal epoxide hydrolase: induction of epoxide hydrolase‐related novel 43 kDa protein. Korean Journal of Pharmacology 1993; 29: 275–282
- Kim S. G., Novak R. F. The induction of cytochrome P4502E1 by nitrogen and sulfur‐containing heterocycles: expression and molecular regulation. Toxicology ind Applied Pharmacology 1993; 120: 257–265
- Knodell R. G., Dubey R. K., Wilkinson G. R., Guengerich F. P. Oxidative metabolism of bexobarbital in human liver: relationship to polymorphic S‐mephenytoin 4‐hydroxylation. Journal of Pharmacology and Experimental Therapeutics 1988; 245: 845–849
- Kwak M. K., Kim S. G., Kwak J. Y., Novak R. F., Kim N. D. Inhibition of cytcchrome P4502E1 expression by organosulfur compounds allylsulfide, allylmercaptan and allylmethyl‐sulfide in rats. Biochemical Pharmacology 1994; 47: 531–539
- Lakmmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 682–685
- Lee E. B., Shin K. H., Woo W. S. Pharmacological study on piperine. Archives of Pharmaceutical Research 1984; 7: 127–132
- Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
- Omura T., Sato R. The carbon monooxide‐binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
- Pei Y. Q. A review of pharmacology and clinical use of piperine and its derivatives. Epilepsia. 1983; 24: 177
- Perry L. M. Medicinal Plants of East and Southeast Asia: Attributed Properties and Uses. MIT, Cambridge 1980
- Shin K. H., Woo W. S. Effect of piperine on hepatic microsomal mixed function oxidase system. Korean Biochemical Journal 1985; 18: 9–15
- Shin K. H., Yun H. S., Woo W. S., Lee C. K. Pharmacologically active principle of Piper retrofractum. Korean Journal of Pharmacognosy 1979; 10: 69–72
- SINGH J., Dubey R. K., Atal C. K. Piperine‐mediated inhibition of glucuronidation activity in isolated epithelial cells of the guinea‐pig small intestine: evidence that piperine lowers the endogeneous UDP‐glucuronic acid content. Journal of Pharmacology and Experimental Therapeutics 1986; 236: 488–493